This study demonstrated the function of the HOXD3–CREBBP/Med15–CCL20–CCR6 axis in regulating invasion and migration in HCC, thus providing new therapeutic targets for HCC. This evidence concerns the gene CCR6 and hepatocellular carcinoma.